1. Home
  2. Live Updates
  3. Guangzhou institute of respiratory health

Live Breaking News & Updates on Guangzhou institute of respiratory health

Stay informed with the latest breaking news from Guangzhou institute of respiratory health on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Guangzhou institute of respiratory health and stay connected to the pulse of your community

The rising burden of respiratory tract cancer in Asia

The rising burden of respiratory tract cancer in Asia
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Jianxing , Sichuan , China , Guangzhou , Guangdong , Chinese , First-affiliated-hospital-of-guangzhou-medical-university , Department-of-thoracic-surgery , Guangzhou-institute-of-respiratory-health , National-clinical-research-center , Key-laboratory-of-respiratory-disease

GSK breathes hope into respiratory biz in country

Global biopharmaceutical company GlaxoSmithKline is scheduled to submit market approvals in China for about 15 new drugs and indications over the next three years and more than 20 clinical research projects will be conducted in the country, said a senior executive of the company.

China , Zhejiang , Guangzhou , Guangdong , Chinese , Shen-huahao , Yu-jinyi , Glaxosmithkline , Zhejiang-university-school-of-medicine , Guangzhou-institute-of-respiratory-health , Chinese-medical-association , United-kingdom-based

Broncus Medical (02216.HK) Announces Annual Results for 2022

/PRNewswire/ -- On March 29, 2023, Broncus Medical (02216.HK), a leader in precise interventional diagnosis and therapy of lung diseases in China, announced...

Japan , United-kingdom , Hangzhou , Zhejiang , China , California , United-states , Malaysia , Germany , Israel , India , Shaanxi

China's Guangzhou sees low rate of severe COVID-19 cases-Xinhua

China's Guangzhou sees low rate of severe COVID-19 cases-

Guangzhou , Guangdong , China , Chinese , Li-yimin , Tang-xiaoping , Hospital-of-guangzhou-medical-university , Guangzhou-institute-of-respiratory-health , Xinhua , Eighth-affiliated-hospital , Guangzhou-medical-university , Guangzhou-institute

China's Guangzhou sees low rate of severe COVID-19 cases

GUANGZHOU, Dec. 8 (Xinhua) -- The southern Chinese city of Guangzhou reported a low rate of severe COVID-19 infections in the recent flare-up, and few local cas

Guangzhou , Guangdong , China , Chinese , Li-yimin , Tang-xiaoping , Hospital-of-guangzhou-medical-university , Guangzhou-institute-of-respiratory-health , Xinhua , Eighth-affiliated-hospital , Guangzhou-medical-university , Guangzhou-institute

Omicron variant spreads faster with lessened virulence, pathogenicity: Chinese respiratory experts

International and domestic monitoring has confirmed that the virulence and pathogenicity of the Omicron variant and its evolutionary branches are significantly reduced compared with the original COVID-19 strain and Delta variants, several Chinese respiratory experts have confirmed.

China , Zhaohui , Heilongjiang , Guangzhou , Guangdong , Beijing , Jilin , Chinese , Li-yimin , Tang-xiaoping , Zhang-wenhong , Zhang-zhongde

China-developed COVID-19 mRNA vaccine as booster safe, immunogenic in clinical trial-Xinhua

China-developed COVID-19 mRNA vaccine as booster safe, immunogenic in clinical trial-

China , Guangzhou , Guangdong , Beijing , Guangzhou-institute-of-respiratory-health , Academy-of-military-medical-sciences , Walvax-biotechnology-co-ltd , Cell-research , Military-medical-sciences , Guangzhou-institute , Respiratory-health

China-developed COVID-19 mRNA vaccine as booster safe, immunogenic in clinical trial

China-developed COVID-19 mRNA vaccine as booster safe, immunogenic in clinical trial
dailytimes.com.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailytimes.com.pk Daily Mail and Mail on Sunday newspapers.

China , Guangzhou , Guangdong , Beijing , Guangzhou-institute-of-respiratory-health , Academy-of-military-medical-sciences , Walvax-biotechnology-co-ltd , Cell-research , Military-medical-sciences , Guangzhou-institute , Respiratory-health

China-developed COVID-19 MRNA Vaccine As Booster Safe, Immunogenic In Clinical Trial

A China-developed mRNA COVID-19 vaccine as a third booster dose has been shown in human trials to be safe and able to induce an immune response against the Omicron variant. AWcorna, previously known as ARCoV, which encodes the receptor-binding domain of SARS-CoV-2 spike protein, is now being tested ..

China , Guangzhou , Guangdong , Beijing , Guangzhou-institute-of-respiratory-health , Walvax-biotechnology-co-ltd , Cell-research , Pakistan-point-news , Military-medical-sciences , Guangzhou-institute , Respiratory-health

健康元(600380):健康元药业集团股份有限公司2021年社会责任报告（英文版）- CFi.CN 中财网

健康元(600380):健康元药业集团股份有限公司2021年社会责任报告（英文版）- CFi.CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.

Taiwan , Tianjin , China , Shanghai , United-states , Hong-kong , Chayu , Jiangxi , Shenzhen , Guangdong , Beijing , Datong